Technology News & Trends

The global bio-MEMS (micro-electro mechanical systems) market is consolidated as few players hold approximately 45% share in the market, observes Transparency Market Research. Baxter International Inc., Medtronic, Becton Dickinson, Boston Scientific, and Abbott Laboratories holds maximum share and dominates the competitive landscape in this market. Leading players in the market are engaged in extensive research and development activities and focusing on developing new product. To maintain their position, players are also focusing on collaboration, mergers and acquisition, expansion, and innovation. According to the TMR’s analysis, the global bio-MEMS market is projected to witness rise at 20.9% CAGR between 2016 and 2024. If the market grows at this rate, there are higher chances that the market valuation will reach US$ 3.8 bn by 2024. In 2015, the market earned US$0.69 bn. These growth rates are related with the increasing demand for accelerometers that fall under various types ...

The global bio-microelectromechanical systems (MEMS) market has been projected in a report by Transparency Market Research (TMR) to bear a fairly consolidated vendor landscape. Boston Scientific, Medtronic, Baxter International Inc., Becton Dickinson, and Abbott Laboratories have been among the leading companies dominating the vendor landscape of the market. An aggregate share of close to a 45.0% had been secured by the top five players operating in the market. With a view to improve their product portfolio, these players have been taking to continuous research and development and the development of novel products with consistent efforts. In order to stay dominant in the market and gain a larger share, companies could consider strategizing key mergers and acquisitions. The global bio-MEMS market has been foreseen in the TMR report to grow at a CAGR of 20.9% during the forecast timeframe 2016-2024. By 2024, the market could bag a US$3.8 bn, after progressing from a valuation of U...